Also, in line with our expectations based on the clinical efficacy of TIL therapy reported in melanoma versus other solid tumors5, a higher proportion of CD8+ TRTs was identified in melanoma relative to other solid tumors (Fig. 2b and Supplementary Table 5). The gene discussed is CD8A; the disease is melanoma.